About Positron Biogenics Limited
Data last updated:
Positron Biogenics Limited is a public limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 20 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2020PLC209376. Its GSTIN is 09AALCP1423E1ZL (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Positron Biogenics Private Limited. It is led by directors including Preety Shukla (Managing Director) and Vikas Shukla (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Noida, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.49 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.86 Cr (net margin 12.2%) and EBITDA of ₹8.68 Cr (EBITDA margin 36.9%). Revenue has grown at a compounded annual rate (CAGR) of 92% over three years.
The company has about 20 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹27.2 Cr on record.
For more details, the company can be reached via its website positronbiogenics.co.in.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/6 – 12 13 14 15 6th Floor It Square, Plot No.21 Sector Knowledge Park III, Noida, Uttar Pradesh, India – 201315
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Positron Biogenics Limited
The main business activity of Positron Biogenics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Positron Biogenics Limited FY 2024 filings available
Positron Biogenics Limited reported revenue of ₹23.49 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Positron Biogenics Limited
Revenue has grown at a compounded annual rate (CAGR) of 92% over three years, including 10% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Positron Biogenics Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.68 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.86 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Positron Biogenics Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Positron Biogenics are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Positron Biogenics Limited
Positron Biogenics Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| B.N.T Imaging Private Limited | ₹23.75 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Credent Healthcare Private Limited | ₹23.73 Cr (FY 2024) | •••• | •••• | 88.0% | •••• | New Delhi, Delhi, India |
| G V Meditech Private Limited | ₹23.71 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Noesis Kronos Private Limited | ₹23.59 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Narnaul, Haryana, India |
| Mishra Polyclinic & Research Centre Pvt Ltd | ₹23.51 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Darbhanga, Bihar, India |
| Positron Biogenics Limited this company | ₹23.49 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Noida, Uttar Pradesh, India |
| Paccs Healthcare Private Limited | ₹23.47 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Hyderabad, Telangana, India |
| SBS Healthcare Services Private Limited | ₹23.3 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Galaxy Superspeciality Hospital and Healthcare Private Limited | ₹23.3 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Jabalpur, Madhya Pradesh, India |
| NS Health Care Services Private Limited | ₹23.14 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Vijayawada, Andhra Pradesh, India |
| Svasth Life Private Limited | ₹22.98 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Positron Biogenics by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Positron Biogenics Limited
Positron Biogenics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Shukla | Whole-Time Director | 10 Nov 2025 | 0 Years 11 Months | Current |
| Bhavya Shukla | Director | 20 May 2020 | 6 Years 4 Months | Current |
| Preety Shukla Also directs: Panacea Multi Super Specialty Hospital Private Limited | Managing Director | 20 May 2020 | 6 Years 4 Months | Current |
Charges & Borrowings of Positron Biogenics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2025 | Sidbi | ₹70 Lakh | Open |
| 29 Nov 2022 | State Bank of India | ₹26.5 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Positron Biogenics Limited
Employment history and EPFO contributions of people linked to Positron Biogenics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Positron Biogenics Limited
Positron Biogenics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24290UP2020PLC209376, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24290UP2020PLC209376 | Current |
| U24290HR2020PTC086287 | Previous |
| U24290UP2020PTC209376 | Previous |
Recent Activity on Positron Biogenics Limited
Positron Biogenics Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Preety Shukla ceased to be Director on 18 Dec 2025.
Credit Ratings, Litigation & Regulatory Alerts for Positron Biogenics Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Positron Biogenics Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Positron Biogenics Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Positron Biogenics Limited
Positron Biogenics has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AALCP1423E1ZL | Uttar Pradesh | Active | 14 Oct 2020 |
| 09AALCP1423E2ZK | Uttar Pradesh | Active | 17 Feb 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Positron Biogenics Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Positron Biogenics Limited
Positron Biogenics is an active public limited company based in Noida, Uttar Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 20 May 2020 (6+ years old) and is registered under CIN U24290UP2020PLC209376.
Positron Biogenics reported revenue of ₹23.49 Cr for FY 2025 (up 10% YoY).
Positron Biogenics has 3 current directors:
- Preety Shukla - Managing Director
- Vikas Shukla - Whole-Time Director
- Bhavya Shukla - Director
Positron Biogenics reported a net profit of ₹2.86 Cr (net margin 12.2%) and EBITDA of ₹8.68 Cr (EBITDA margin 36.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Positron Biogenics is 92% over three years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Positron Biogenics is 09AALCP1423E1ZL, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AALCP1423E2ZK (Uttar Pradesh).
The CIN (Corporate Identification Number) of Positron Biogenics is U24290UP2020PLC209376. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Positron Biogenics was incorporated on 20 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Positron Biogenics by revenue are B.N.T Imaging Private Limited, Credent Healthcare Private Limited, G V Meditech Private Limited, Noesis Kronos Private Limited, Mishra Polyclinic & Research Centre Pvt Ltd and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Preety Shukla ceased to be Director on 18 Dec 2025. Vikas Shukla ceased to be Director on 18 Dec 2025. Vikas Shukla was appointed as Whole-Time Director on 10 Nov 2025. Positron Biogenics has 5 board changes on record in total.
Yes, Positron Biogenics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).